Plant Advanced Technologies SA (ALPAT) - Net Assets
Based on the latest financial reports, Plant Advanced Technologies SA (ALPAT) has net assets worth €9.11 Million EUR (≈ $10.65 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€15.59 Million ≈ $18.22 Million USD) and total liabilities (€6.48 Million ≈ $7.58 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Plant Advanced Technologies SA to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €9.11 Million |
| % of Total Assets | 58.43% |
| Annual Growth Rate | 28.68% |
| 5-Year Change | 7.33% |
| 10-Year Change | 118737.76% |
| Growth Volatility | 28919.13 |
Plant Advanced Technologies SA - Net Assets Trend (2008–2024)
This chart illustrates how Plant Advanced Technologies SA's net assets have evolved over time, based on quarterly financial data. See Plant Advanced Technologies SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Plant Advanced Technologies SA (2008–2024)
The table below shows the annual net assets of Plant Advanced Technologies SA from 2008 to 2024. For live valuation and market cap data, see Plant Advanced Technologies SA market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €9.17 Million ≈ $10.72 Million |
+12.74% |
| 2023-12-31 | €8.13 Million ≈ $9.51 Million |
+19.78% |
| 2022-12-31 | €6.79 Million ≈ $7.94 Million |
-8.03% |
| 2021-12-31 | €7.38 Million ≈ $8.63 Million |
-13.57% |
| 2020-12-31 | €8.54 Million ≈ $9.98 Million |
-14.62% |
| 2019-12-31 | €10.00 Million ≈ $11.69 Million |
+119514.41% |
| 2018-12-31 | €8.36K ≈ $9.78K |
+30.48% |
| 2017-12-31 | €6.41K ≈ $7.49K |
-2.72% |
| 2016-12-31 | €6.59K ≈ $7.70K |
-14.59% |
| 2015-12-31 | €7.71K ≈ $9.02K |
+227.58% |
| 2014-12-31 | €2.35K ≈ $2.75K |
-99.89% |
| 2013-12-31 | €2.10 Million ≈ $2.45 Million |
-2.60% |
| 2012-12-31 | €2.15 Million ≈ $2.51 Million |
+3.64% |
| 2011-12-31 | €2.08 Million ≈ $2.43 Million |
-7.58% |
| 2010-12-31 | €2.25 Million ≈ $2.63 Million |
+292.93% |
| 2009-12-31 | €571.54K ≈ $668.19K |
+252.19% |
| 2008-12-31 | €162.28K ≈ $189.72K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Plant Advanced Technologies SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €1.12 Million | 11.43% |
| Other Components | €8.71 Million | 88.57% |
| Total Equity | €9.84 Million | 100.00% |
Plant Advanced Technologies SA Competitors by Market Cap
The table below lists competitors of Plant Advanced Technologies SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lupaka Gold Corp.
V:LPK
|
$7.11 Million |
|
Dynasty Gold Corp
V:DYG
|
$7.12 Million |
|
Treasure Global Inc.
NASDAQ:TGL
|
$7.12 Million |
|
Perrot Duval Holding SA
SW:PEDU
|
$7.13 Million |
|
Industrial Minerals Ltd
AU:IND
|
$7.10 Million |
|
Syncona Limited
LSE:SYNC
|
$7.10 Million |
|
Meihua International Medical Technologies Co. Ltd.
NASDAQ:MHUAF
|
$7.10 Million |
|
Advanced Blockchain AG
XETRA:BWQ
|
$7.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Plant Advanced Technologies SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,166,206 to 9,839,000, a change of 672,794 (7.3%).
- Net income of 569,402 contributed positively to equity growth.
- Other factors increased equity by 103,392.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €569.40K | +5.79% |
| Other Changes | €103.39K | +1.05% |
| Total Change | €- | 7.34% |
Book Value vs Market Value Analysis
This analysis compares Plant Advanced Technologies SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.62x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.83x to 0.62x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | €2.95 | €5.40 | x |
| 2012-12-31 | €2.19 | €5.40 | x |
| 2013-12-31 | €3.49 | €5.40 | x |
| 2014-12-31 | €0.00 | €5.40 | x |
| 2015-12-31 | €0.01 | €5.40 | x |
| 2016-12-31 | €0.01 | €5.40 | x |
| 2017-12-31 | €0.01 | €5.40 | x |
| 2018-12-31 | €0.01 | €5.40 | x |
| 2019-12-31 | €9.25 | €5.40 | x |
| 2020-12-31 | €6.96 | €5.40 | x |
| 2021-12-31 | €5.86 | €5.40 | x |
| 2022-12-31 | €5.06 | €5.40 | x |
| 2023-12-31 | €7.19 | €5.40 | x |
| 2024-12-31 | €8.25 | €5.40 | x |
| 2025-12-31 | €8.75 | €5.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Plant Advanced Technologies SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.79%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 50.04%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.66x
- Recent ROE (5.79%) is above the historical average (-4.51%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 1.18% | 2.25% | 0.16x | 3.27x | €-14.31K |
| 2009 | -7.69% | -45.77% | 0.09x | 1.79x | €-101.10K |
| 2010 | -1.89% | -22.09% | 0.05x | 1.82x | €-210.36K |
| 2011 | 1.44% | 12.11% | 0.07x | 1.60x | €-153.67K |
| 2012 | 12.06% | 28.28% | 0.26x | 1.65x | €44.22K |
| 2013 | -3.15% | -5.47% | 0.28x | 2.03x | €-275.56K |
| 2014 | -25.25% | -35.31% | 0.31x | 2.34x | €-830.09 |
| 2015 | -11.60% | -47.61% | 0.18x | 1.35x | €-1.67K |
| 2016 | -17.08% | -71.36% | 0.16x | 1.49x | €-1.78K |
| 2017 | -10.53% | -46.14% | 0.15x | 1.53x | €-1.32K |
| 2018 | 10.34% | 46.17% | 0.15x | 1.52x | €28.21 |
| 2019 | -5.41% | -46.15% | 0.08x | 1.39x | €-1.54 Million |
| 2020 | -7.21% | -31.59% | 0.10x | 2.29x | €-1.30 Million |
| 2021 | -17.84% | -49.20% | 0.13x | 2.69x | €-1.77 Million |
| 2022 | -15.42% | -36.30% | 0.14x | 3.10x | €-1.40 Million |
| 2023 | 0.97% | 4.71% | 0.11x | 1.83x | €-733.89K |
| 2024 | 10.20% | 48.52% | 0.12x | 1.75x | €18.51K |
| 2025 | 5.79% | 50.04% | 0.07x | 1.66x | €-414.50K |
Industry Comparison
This section compares Plant Advanced Technologies SA's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $9,461,229
- Average return on equity (ROE) among peers: -5513.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Plant Advanced Technologies SA (ALPAT) | €9.11 Million | 1.18% | 0.71x | $7.11 Million |
| Abionyx Pharma SA (ABNX) | $12.00K | -54691.67% | 902.08x | $90.53 Million |
| Abivax SA (ABVX) | $34.02 Million | -17.32% | 0.13x | $7.88 Billion |
| Adocia (ADOC) | $19.13 Million | -22.44% | 0.29x | $93.64 Million |
| Aelis Farma SA (AELIS) | $1.20 Million | -263.37% | 5.00x | $15.94 Million |
| Biophytis S.A. (ALBPS) | $125.60K | 0.00% | 8.63x | $752.91K |
| Cellectis (ALCLS) | $6.40 Million | 0.00% | 0.20x | $226.59 Million |
| Advicenne (ALDVI) | $16.92 Million | -83.89% | 0.35x | $18.51 Million |
| Genoway (ALGEN) | $16.17 Million | 4.81% | 1.04x | $31.09 Million |
| Integragen (ALINT) | $5.13 Million | -56.43% | 0.59x | $1.00 Million |
| Medesis Pharma SA (ALMDP) | $-4.50 Million | 0.00% | 0.00x | $1.80 Million |
About Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more